Related Experiment Videos
High activity iodine 125 endocurietherapy for recurrent skull base tumors
P P Kumar1, R R Good, L G Leibrock
1Division of Radiation Oncology, University of Nebraska College of Medicine, Omaha.
Cancer
|April 15, 1988
Abstract:
Experience with endocurietherapy of skull base tumors is reviewed. We present our cases of recurrent pituitary hemangiopericytoma, radiation-induced recurrent meningioma, recurrent clival chordoma, recurrent nasopharyngeal cancer involving the cavernous sinus, and recurrent parotid carcinoma of the skull base which were all successfully retreated with high-activity 125iodine (I-125) permanent implantation.